These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3649202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
    [Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 4. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Gilbert M, Boscia JA, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):382-4. PubMed ID: 3640590
    [Abstract] [Full Text] [Related]

  • 6. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Barriere SL, Schaberg DR, Fekety R.
    J Antimicrob Chemother; 1987 Nov; 20(5):753-8. PubMed ID: 3429376
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1547-50. PubMed ID: 1929325
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 15. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Aeschlimann JR, Houlihan HH, Mercier RC, Rybak MJ.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):981-3. PubMed ID: 9559828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.